Screening for bowel cancer: An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test

Marie E Westwood; Hanyu Wang; Shona Kirtley; Stella O'Brien; Penny F Whiting; Hayley E Jones

doi:10.5281/zenodo.18701443

Screening for bowel cancer: An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test

Marie E Westwood, Hanyu Wang, Shona Kirtley, Stella O'Brien, Penny F Whiting, Hayley E Jones

Research output: Book/Report › Commissioned report

Abstract

This document discusses the findings of an evidence map completed by the Bristol Evidence Synthesis for Screening (BESS) Group at the University of Bristol.

We were commissioned by the UK National Screening Committee (UK NSC) to produce an evidence map to look at the evidence related to Bowel Cancer Screening Triage Tests. An evidence map is a rapid evidence product which aims to gauge the volume and type of evidence relating to a specific topic.

This report was commissioned by the NIHR Evidence Synthesis Programme. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

Original language	English
Publisher	Zenodo
Number of pages	46
DOIs	https://doi.org/10.5281/zenodo.18701443
Publication status	Published - 1 Aug 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Research Groups and Themes

BESS

Keywords

Screening

Access to Document

10.5281/zenodo.18701443Licence: CC BY

Handle.net

Persistent link

Fingerprint

Dive into the research topics of 'Screening for bowel cancer: An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test'. Together they form a unique fingerprint.

Cite this

Westwood, M. E., Wang, H., Kirtley, S., O'Brien, S., Whiting, P. F., & Jones, H. E. (2025). Screening for bowel cancer: An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test. Zenodo. https://doi.org/10.5281/zenodo.18701443

@book{69b5fcdd22644eba8de622423b54227e,

title = "Screening for bowel cancer: An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test",

abstract = "This document discusses the findings of an evidence map completed by the Bristol Evidence Synthesis for Screening (BESS) Group at the University of Bristol. We were commissioned by the UK National Screening Committee (UK NSC) to produce an evidence map to look at the evidence related to Bowel Cancer Screening Triage Tests. An evidence map is a rapid evidence product which aims to gauge the volume and type of evidence relating to a specific topic. This report was commissioned by the NIHR Evidence Synthesis Programme. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care. ",

keywords = "Screening",

author = "Westwood, \{Marie E\} and Hanyu Wang and Shona Kirtley and Stella O'Brien and Whiting, \{Penny F\} and Jones, \{Hayley E\}",

year = "2025",

month = aug,

day = "1",

doi = "10.5281/zenodo.18701443",

language = "English",

publisher = "Zenodo",

address = "Switzerland",

}

Westwood, ME , Wang, H , Kirtley, S, O'Brien, S, Whiting, PF & Jones, HE 2025, Screening for bowel cancer: An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test. Zenodo. https://doi.org/10.5281/zenodo.18701443

Screening for bowel cancer: An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test. / Westwood, Marie E ; Wang, Hanyu ; Kirtley, Shona et al.
Zenodo, 2025. 46 p.

Research output: Book/Report › Commissioned report

TY - BOOK

T1 - Screening for bowel cancer

T2 - An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test

AU - Westwood, Marie E

AU - Wang, Hanyu

AU - Kirtley, Shona

AU - O'Brien, Stella

AU - Whiting, Penny F

AU - Jones, Hayley E

PY - 2025/8/1

Y1 - 2025/8/1

N2 - This document discusses the findings of an evidence map completed by the Bristol Evidence Synthesis for Screening (BESS) Group at the University of Bristol. We were commissioned by the UK National Screening Committee (UK NSC) to produce an evidence map to look at the evidence related to Bowel Cancer Screening Triage Tests. An evidence map is a rapid evidence product which aims to gauge the volume and type of evidence relating to a specific topic. This report was commissioned by the NIHR Evidence Synthesis Programme. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

AB - This document discusses the findings of an evidence map completed by the Bristol Evidence Synthesis for Screening (BESS) Group at the University of Bristol. We were commissioned by the UK National Screening Committee (UK NSC) to produce an evidence map to look at the evidence related to Bowel Cancer Screening Triage Tests. An evidence map is a rapid evidence product which aims to gauge the volume and type of evidence relating to a specific topic. This report was commissioned by the NIHR Evidence Synthesis Programme. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.

KW - Screening

U2 - 10.5281/zenodo.18701443

DO - 10.5281/zenodo.18701443

M3 - Commissioned report

BT - Screening for bowel cancer

PB - Zenodo

ER -

Westwood ME , Wang H , Kirtley S, O'Brien S, Whiting PF , Jones HE. Screening for bowel cancer: An evidence map to outline the volume and type of evidence related to modifying the NHS Bowel Cancer Screening Programme, to include blood-based liquid biopsy triage tests for people who test positive on a faecal immunochemical test. Zenodo, 2025. 46 p. doi: 10.5281/zenodo.18701443